National Account Director

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values:
One, Explore, Disrupt, Deliver and feel strongly that you can achieve more  have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We want all of our people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just "treat" people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

The National Account Director - Public Payer will play a critical leadership role in shaping and executing our U.S. market access strategy with state Medicaid programs, Medicaid Managed Care Organizations (MCOs), federal payers, and select regional government-affiliated health plans in preparation for our first gene editing therapy launch. This is a high-impact, field-based position responsible for building relationships with key government payer stakeholders, communicating product value, and securing favorable coverage and reimbursement pathways within the unique regulatory and budgetary framework of public payer systems.

This is a highly strategic, hands-on role that is ideal for an experienced national account professional who thrives in fast-paced, build-from-scratch environments and understands the complexity of launching innovative, high-value therapies in Medicaid and government-funded healthcare programs.

Duties/Responsibilities

Key Responsibilities:

* Lead strategic engagement with:

* State Medicaid programs (FFS and managed care), Medicaid MCOs (e.g., Centene, Molina, United Healthcare Community & State, Elevance Medicaid plans

* Federal/government payers (e.g., VA, DoD/TRICARE, IHS) to cover VISNs and MTFs; and interact with the DOD P&T and VA PBM as needed.

* Build and manage relationships with key decision-makers across:

* Medicaid:
Medicaid agencies, state pharmacy directors, P&T committees, and Medicaid MCO medical/pharmacy leadership.

* Federal: VA PBM, DOD P&T, BAP, MTFs and VISNs

* Navigate the unique regulatory, legislative, and budgetary constraints of Medicaid programs, including understanding Drug Rebate Program requirements, Best Price implications, and state budgetary cycles.

* Analyze state-specific Medicaid policies, utilization management criteria, and preferred drug lists (PDLs) to anticipate coverage barriers and inform access strategies.

* Develop and execute early account engagement plans in anticipation of launch, educating Medicaid stakeholders on gene editing science, disease burden, patient population overlap with Medicaid beneficiaries, and anticipated value proposition-with sensitivity to health equity and access considerations.

* Partner with internal teams (Market Access Strategy, Contracts and Pricing, HEOR, Medical Affairs, Clinical, Regulatory, Patient Services) to develop and tailored payer-facing materials, including early scientific exchange, evidence dossiers, state-specific budget impact models, PIE presentations, and health equity analyses.

* Drive Medicaid payer insight generation to inform state-level advocacy efforts in pre-launch and launch phases.

* Collaborate with internal teams to monitor state legislation, Medicaid policy developments, and advocacy opportunities that impact access to gene editing and high-cost cell & gene therapies.

* Work closely with internal launch and hub teams to support pull-through planning, specialty pharmacy/distribution strategy specific to Medicaid (e.g., 340B considerations), and affordability/access solutions tailored to Medicaid populations.

* If required, identify, shape, and lead negotiation of value-based, outcomes-based, or performance-based supplemental rebate agreements aligned with company objectives, product profile, and Medicaid/MCO priorities.

* Monitor and influence Medicaid policy development, coverage determinations, and utilization management protocols relevant to gene editing and transformative therapies, including participation in and coordination of cross-functional team members in P&T and DUR meetings for strategic states

* Monitor Federal policy and formula placement in the VA and DOD; including submission of DOD RFP formulary bid

* Serve as the internal voice of Medicaid and government payers, providing strategic guidance to leadership on coverage risks, opportunities, health equity implications, and market dynamics unique to public payer systems.

* Ensure all engagements and materials are fully compliant with legal, regulatory, compliance, and corporate standards, including OIG guidance, Anti-Kickback Statute,…